DiRx and TSC Alliance® Partner to Bring Affordable Prescription Medicines to Patients With Tuberous Sclerosis Complex (TSC) | Business

EAST BRUNSWICK, NJ–(BUSINESS WIRE)–May 16, 2022–

Today, DiRx, a fast-growing digital pharmacy platform focused on generic drug access and affordability, announced a new partnership with TSC Alliance®, a nonprofit organization dedicated to finding a remedy for Tuberous Sclerosis Complex (TSC) while improving the lives of those affected. . TSC causes tumor formation in vital organs and is the main genetic cause of epilepsy. About 50,000 in the United States and 1 million worldwide have TSC.

DiRx will offer the industry’s lowest prices on generic medications commonly used by patients with manifestations of TSC, including seizures. TSC patients with a valid prescription in the United States will be able to save up to 79% over the average retail price on two commonly prescribed drugs for this disease, everolimus and sirolimus, and receive free shipping to United States, no insurance required.

The TSC Alliance is pleased to partner with DiRx to ensure that anyone affected by TSC has access to the medications they need,” said Kari Luther Rosbeck, President and CEO. “We are grateful to DiRx for helping those we serve obtain affordable prescriptions at reduced prices.”

The DiRx team is very pleased to have enabled significant cost savings for TSC patients through its disruptive Direct Sourcing and Direct Fulfillment model that eliminates multiple layers of the supply chain. Depending on the specific product sku and dosage required, DiRx can save over $2,000 per month in some cases. This partnership marks another successful step in our goal of enabling prescription access and affordability for all Americans. said Satish Srinivasan, Founder and CEO of DiRx.

In addition to these essential TSC medications, DiRx offers over 1,400 FDA-approved generic medications at prices as low as $3 per month, including free shipping. Ordering medication from DiRx does not require prior approval or insurance. To help more consumers access essential medicines, for a limited time, a 30-day supply (up to $100 per order) is also available free to TSC patients, with code TSC30DAYS.

About DiRx

DiRx is an online pharmacy that offers savings on commonly prescribed, FDA-approved generic drugs without the need for insurance. Founded by industry experts, DiRx draws a straight line from supply to demand to streamline the path from manufacturer to consumer. This reduces costs and makes more drugs available to more people. DiRx offers a viable model for businesses and community organizations while simplifying how consumers fill out, pay for, and receive maintenance medications. To learn more, visit DiRxHealth.com or call 877-FOR-DIRX (877-367-3479). You can also find DiRx on social networks: Facebook, instagram, Twitter and LinkedIn.

About the TSC Alliance

The TSC Alliance is an internationally renowned non-profit organization dedicated to improving the lives of people with tuberous sclerosis. It stimulates research, improves the quality of care, works to improve access, inspires hope and advocates with and for all those affected by the disease. Learn more about tscalliance.org.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220516005669/en/

CONTACT: For media inquiries, please contact

Simone Grapini-Goodman, Marketing Director

Email: [email protected]

https://www.dirxhealth.com/press

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: GENERAL HEALTH OTHER HEALTH PHARMACEUTICAL PRACTICE MANAGEMENT

SOURCE: DiRx

Copyright BusinessWire 2022.

PUBLISHED: 05/16/2022 10:17 AM/DISC: 05/16/2022 10:17 AM

http://www.businesswire.com/news/home/20220516005669/en

Copyright BusinessWire 2022.